Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2017 ASCO Annual Meeting

2 - 6 Jun 2017
McCormick Place, Chicago, United States of America
Low-value practices in oncology contributing to financial toxicity
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
Low-value practices in oncology contributing to financial toxicity ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
5 Jul 2017
The past and future of breast cancer treatment—from the papyrus to individualise...
Dr Felipe Ades - Hospital Israelita Albert Einstein, Morumbi, São Paulo
The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches ( Dr Felipe Ades - Hospital Israelita Albert Einstein, Morumbi, São Paulo )
5 Jul 2017
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate can...
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(2/6) ASCO 2017: LATITUDE data
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(2/6) ASCO 2017: LATITUDE data ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(3/6) ASCO 2017: STAMPEDE data
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(3/6) ASCO 2017: STAMPEDE data ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(5/6) ASCO 2017: ASCO highlights in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(5/6) ASCO 2017: ASCO highlights in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
Clinical potential of trastuzumab biosimilar CTP6
Prof Francisco Esteva - NYU Langone Medical Center, New York, USA
Clinical potential of trastuzumab biosimilar CTP6 ( Prof Francisco Esteva - NYU Langone Medical Center, New York, USA )
8 Jun 2017
ASCO 2017: Round up
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ASCO 2017: Round up ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
6 Jun 2017
Updates in melanoma: Treating BRAF and brain metastases
Prof Georgina Long - University of Sydney, Sydney, Australia
Updates in melanoma: Treating BRAF and brain metastases ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Jun 2017
Bendamustine for indolent lymphoma reduces relapse after 10 years
Dr Mathias Rummel - University of Giessen, Giessen, Germany
Bendamustine for indolent lymphoma reduces relapse after 10 years ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
5 Jun 2017
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year
Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
5 Jun 2017
T-VEC and checkpoint therapy for melanoma
Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
T-VEC and checkpoint therapy for melanoma ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017
Prevalence of homologous recombination deficiency among 53,000 tumour samples
Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, ...
Prevalence of homologous recombination deficiency among 53,000 tumour samples ( Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )
5 Jun 2017
Natural plant based balm antidote to severe nail toxicity during chemotherapy
Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK
Natural plant based balm antidote to severe nail toxicity during chemotherapy ( Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK )
5 Jun 2017
Dacomitinib for EGFR positive lung cancer
Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China
Dacomitinib for EGFR positive lung cancer ( Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China )
5 Jun 2017
New ALK inhibitor alectinib halts lung cancer growth more than a year longer tha...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017
ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
5 Jun 2017
ASCO 2017: Following the practice changing results from STAMPEDE
Dr Neal Shore and Prof Nicholas James
ASCO 2017: Following the practice changing results from STAMPEDE ( Dr Neal Shore and Prof Nicholas James )
5 Jun 2017
Treating advanced melanoma with ipilimumab and HF10
Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
Treating advanced melanoma with ipilimumab and HF10 ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
5 Jun 2017
Immunotherapy may slow the growth of malignant pleural mesothelioma
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy may slow the growth of malignant pleural mesothelioma ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
Immunotherapy for mesothelioma could be on the horizon
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy for mesothelioma could be on the horizon ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
CAR T-cell therapy can be used to send multiple myeloma into lasting remission
Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China
CAR T-cell therapy can be used to send multiple myeloma into lasting remission ( Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China )
5 Jun 2017
Alectinib eclipses crizotinib for ALK positive lung cancer
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Alectinib eclipses crizotinib for ALK positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017
Adding a second HER2 targeted medicine may lower chance of invasive breast cance...
Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding a second HER2 targeted medicine may lower chance of invasive breast cancer ( Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
5 Jun 2017
Targeted sequencing in endocrine refractory breast cancer
Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada
Targeted sequencing in endocrine refractory breast cancer ( Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada )
5 Jun 2017
Results from the APHINITY trial of two HER2 targeted agents with chemo
Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Results from the APHINITY trial of two HER2 targeted agents with chemo ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
5 Jun 2017
Treating BRCA breast cancer with PARP inhibition
Dr Mika Sovak - AstraZeneca, Cambridge, UK
Treating BRCA breast cancer with PARP inhibition ( Dr Mika Sovak - AstraZeneca, Cambridge, UK )
4 Jun 2017
Relieving spinal cord compression symptoms with a single radiation treatment
Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom
Relieving spinal cord compression symptoms with a single radiation treatment ( Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom )
4 Jun 2017
Implementing new health initiatives in low-resource environments
Prof Sana Al Sakhun - Jordanian Oncology Society, Jordan
Implementing new health initiatives in low-resource environments ( Prof Sana Al Sakhun - Jordanian Oncology Society, Jordan )
4 Jun 2017
Halving duration of ADT for high risk prostate cancer patients
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Halving duration of ADT for high risk prostate cancer patients ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
4 Jun 2017
New personalised therapies for lung cancer
Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA
New personalised therapies for lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )
4 Jun 2017
Findings of a phase I/II study of nivolumab in patients with virus-associated tu...
Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France
Findings of a phase I/II study of nivolumab in patients with virus-associated tumours ( Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France )
4 Jun 2017
Nivolumab and ipilimumab for metastatic sarcoma
Dr Sandra D'Angelo - Memorial Sloan Kettering Cancer Center, New York, USA
Nivolumab and ipilimumab for metastatic sarcoma ( Dr Sandra D'Angelo - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Selumetinib in children with recurrent or refractory low-grade glioma
Dr Jason Fangusaro - Ann & Robert H. Lurie Children's Hospital of Chicago, Chica...
Selumetinib in children with recurrent or refractory low-grade glioma ( Dr Jason Fangusaro - Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA )
4 Jun 2017
Dose escalation results of ceritinib and nivolumab for ALK NSCLC
Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain
Dose escalation results of ceritinib and nivolumab for ALK NSCLC ( Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain )
4 Jun 2017
Phase III results of olaparib for BRCA breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Phase III results of olaparib for BRCA breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Global health initiative oncology
Prof Ophira Ginsburg - NYU Langone Medical Center, New York, USA
Global health initiative oncology ( Prof Ophira Ginsburg - NYU Langone Medical Center, New York, USA )
4 Jun 2017
Self-reporting symptoms online improves patient care, chemotherapy duration and ...
Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of N...
Self-reporting symptoms online improves patient care, chemotherapy duration and survival ( Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of North Carolina, USA )
4 Jun 2017
Tivantinib as second line therapy for high-MET HCC
Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy
Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )
4 Jun 2017
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy
Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy ( Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy )
4 Jun 2017
Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiolo...
Dr Chris Parker and Prof Charles Ryan
Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment ( Dr Chris Parker and Prof Charles Ryan )
4 Jun 2017
Web-based system for self-reporting symptoms may help patients live longer
Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of N...
Web-based system for self-reporting symptoms may help patients live longer ( Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of North Carolina, USA )
4 Jun 2017
Olaparib slows growth of BRCA-related metastatic breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Olaparib slows growth of BRCA-related metastatic breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Global study sets new risk-based standard to personalise chemotherapy for colon ...
Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA
Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery ( Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA )
4 Jun 2017
3 or 6 months adjuvant oxaliplatin for colorectal cancer
Dr Tim Iveson - University Hospital Southampton, Salisbury, UK
3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )
4 Jun 2017
No link between pregnancy and breast cancer relapse
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
No link between pregnancy and breast cancer relapse ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
4 Jun 2017
Cancer and caring in modern medicine
Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA
Cancer and caring in modern medicine ( Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA )
4 Jun 2017
Pooled analysis of avelumab for metastatic urothelial carcinoma
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
3 Jun 2017
Cancer and living meaningfully: the CALM intervention
Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada
Cancer and living meaningfully: the CALM intervention ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2017
'Conquer Fear' of disease recurrence
Dr Jane Beith - University of Sydney, Sydney, Australia
'Conquer Fear' of disease recurrence ( Dr Jane Beith - University of Sydney, Sydney, Australia )
3 Jun 2017
Screening for 508 genes in liquid biopsy to chart cancer evolution
Dr Pedram Razavi - Memorial Sloan Kettering Cancer Centre, New York, USA
Screening for 508 genes in liquid biopsy to chart cancer evolution ( Dr Pedram Razavi  - Memorial Sloan Kettering Cancer Centre, New York, USA )
3 Jun 2017
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers ( Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA )
3 Jun 2017
Routine genomic testing is feasible, but only a subset of patients benefit
Dr Olivier Trédan - Centre Léon Bérard, Lyon, France
Routine genomic testing is feasible, but only a subset of patients benefit ( Dr Olivier Trédan - Centre Léon Bérard, Lyon, France )
3 Jun 2017
Molecular profiles and the future of adjuvant therapy
Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiles and the future of adjuvant therapy ( Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
3 Jun 2017
Pregnancy after breast cancer no associated with relapse risk
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Pregnancy after breast cancer no associated with relapse risk ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
3 Jun 2017
Delaying metastatic prostate cancer, improving survival with abiraterone
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Delaying metastatic prostate cancer, improving survival with abiraterone ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
3 Jun 2017
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/dea...
Prof Nick James - Queen Elizabeth Hospital Birmingham & University of Birmingham...
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/deaths ( Prof Nick James - Queen Elizabeth Hospital Birmingham & University of Birmingham, UK )
3 Jun 2017
Hypogonadism following cisplatin treatment of testicular cancer
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis...
Hypogonadism following cisplatin treatment of testicular cancer ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Recent childhood cancer survivors face less chronic disease risk than previous d...
Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA
Recent childhood cancer survivors face less chronic disease risk than previous decades ( Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA )
2 Jun 2017
Steady decrease in severe health problems for childhood cancer survivors
Dr Todd M. Gibson - St Jude Children's Research Hospital, Memphis, USA
Steady decrease in severe health problems for childhood cancer survivors ( Dr Todd M. Gibson - St Jude Children's Research Hospital, Memphis, USA )
2 Jun 2017
Low testosterone after testicular cancer could be linked to chronic health probl...
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis...
Low testosterone after testicular cancer could be linked to chronic health problems ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Single radiation treatment can sufficiently relieve spinal cord compression symp...
Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom
Single radiation treatment can sufficiently relieve spinal cord compression symptoms ( Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom )
2 Jun 2017
Web-based remote therapy program improves quality of life and lowers distress af...
Dr Viviane Hess - University Hospital of Basel, Basel, Switzerland
Web-based remote therapy program improves quality of life and lowers distress after diagnosis ( Dr Viviane Hess - University Hospital of Basel, Basel, Switzerland )
2 Jun 2017
Easing distress in patients with cognitive therapy
Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada
Easing distress in patients with cognitive therapy ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )
2 Jun 2017
Psychological intervention lowers fear of cancer recurrence
Dr Jane Beith - University of Sydney, Australia
Psychological intervention lowers fear of cancer recurrence ( Dr Jane Beith - University of Sydney, Australia )
2 Jun 2017